To evaluate combination therapy in vivo, we developed a unique ERBB2+ BC orthotopic nude mouse model of spontaneous metastasis that showed primary tumor growth and clinically relevant distant metastasis to brain, bone, liver, and lung. This evidence concerns the gene ERBB2 and neoplasm.